| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 |
| filingDate |
2014-03-13^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9cca8e7ae5d1ebcb515aad9b4a92bdf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a84dee49065d06589caa51042513a65c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fce7c6822b771c591c481693c9db156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fab235a66214dc8987ff7317cd7e5085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_710010e06159505706cbcadd051f5d5f |
| publicationDate |
2015-10-08^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2014229283-A1 |
| titleOfInvention |
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH |
| abstract |
The invention is directed to a formula (I): or a pharmaceutically acceptable salt thereof, wherein R |
| priorityDate |
2013-03-14^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |